Outcomes of same-sizing versus oversizing donor trephines in keratoconic patients undergoing first penetrating keratoplasty

Ophthalmology. 2008 Feb;115(2):268-75. doi: 10.1016/j.ophtha.2007.04.051.

Abstract

Purpose: To investigate whether use of same-size donor and recipient trephines reduced myopia after penetrating keratoplasty for keratoconus.

Design: Retrospective cohort study.

Participants: Eight hundred seventy-eight first grafts for keratoconus were reported to UK Transplant between April 1999 and December 2003. There were 234 and 644 grafts in the same-size and oversize donor trephine groups, respectively. At 1 year, mean spherical equivalent (SE) data were available for 116 eyes (50%) and 295 eyes (46%) in the same-size and oversize groups. At 2 years, mean SE data were available for 64 eyes (27%) and 148 eyes (23%) in the same-size and oversize groups.

Methods: Logistic regression and univariate analysis of follow-up data submitted to UK Transplant.

Main outcome measures: At 1 and 2 years postoperatively, mean SE, magnitude of the cylindrical component of the refraction, postoperative uncorrected visual acuity (VA), postoperative best-corrected VA, and postoperative complications were recorded.

Results: The mean SEs for the same-size and oversize donor trephine groups, respectively, were -1.45 diopters (D) and -1.41 D at 1 year (P = 0.6) and -1.74 D and -2.19 D at 2 years postoperatively (P = 0.3). Although there were no differences in graft survival between the groups at 1 and 2 years, there was a higher incidence of postoperative wound leaks in the same-size group (P = 0.03).

Conclusion: Use of same-size donor and recipient trephines did not reduce myopia and was associated with an increased risk of postoperative complications.

MeSH terms

  • Adult
  • Cornea / pathology*
  • Female
  • Follow-Up Studies
  • Graft Survival
  • Humans
  • Keratoconus / surgery*
  • Keratoplasty, Penetrating / methods*
  • Male
  • Myopia / prevention & control
  • Postoperative Complications
  • Retrospective Studies
  • Tissue Donors*
  • Treatment Outcome
  • Visual Acuity